RORγ expression is downregulated in patients suffering from aggressive basal-like breast cancer and bladder cancer, supporting the important modulatory role of RORγ in the regulation of carcinogenesis and tumor suppression [3,17]. The gene discussed is RORC; the disease is breast cancer.